About Internistische Gemeinschaftspraxis - Offenbach
Clinical Trials at Internistische Gemeinschaftspraxis - Offenbach
During the past decade, Internistische Gemeinschaftspraxis - Offenbach conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Internistische Gemeinschaftspraxis - Offenbach" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "Pfizer" with 2 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Internistische Gemeinschaftspraxis - Offenbach"
#1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Internistische Gemeinschaftspraxis - Offenbach
According to Clinical.Site data, the most researched conditions in "Internistische Gemeinschaftspraxis - Offenbach" are
"Chronic Lymphocytic Leukemia" (4 trials), "Cardiovascular Disease" (2 trials), "Breast Cancer" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Internistische Gemeinschaftspraxis - Offenbach" in a lesser frequency.
Clinical Trials Intervention Types at Internistische Gemeinschaftspraxis - Offenbach
Most popular intervention types in "Internistische Gemeinschaftspraxis - Offenbach" are "Drug" (9 trials), "Biological" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (4 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Internistische Gemeinschaftspraxis - Offenbach
The vast majority of trials in "Internistische Gemeinschaftspraxis - Offenbach" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Internistische Gemeinschaftspraxis - Offenbach
Currently, there are NaN active trials in "Internistische Gemeinschaftspraxis - Offenbach".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Internistische Gemeinschaftspraxis - Offenbach,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Internistische Gemeinschaftspraxis - Offenbach, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".